Toll Free: 1-888-928-9744
Published: Apr, 2014 | Pages:
31 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Advanced Cell Technology, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Advanced Cell Technology, Inc. - Product Pipeline Review - 2014', provides an overview of the Advanced Cell Technology, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Advanced Cell Technology, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Advanced Cell Technology, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Advanced Cell Technology, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Advanced Cell Technology, Inc.'s pipeline products Reasons to buy - Evaluate Advanced Cell Technology, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Advanced Cell Technology, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Advanced Cell Technology, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Advanced Cell Technology, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Advanced Cell Technology, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Advanced Cell Technology, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Advanced Cell Technology, Inc. Snapshot 4 Advanced Cell Technology, Inc. Overview 4 Key Information 4 Key Facts 4 Advanced Cell Technology, Inc. - Research and Development Overview 5 Key Therapeutic Areas 5 Advanced Cell Technology, Inc. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Advanced Cell Technology, Inc. - Pipeline Products Glance 9 Advanced Cell Technology, Inc. - Clinical Stage Pipeline Products 9 Phase I Products/Combination Treatment Modalities 9 Advanced Cell Technology, Inc. - Early Stage Pipeline Products 10 Preclinical Products/Combination Treatment Modalities 10 Advanced Cell Technology, Inc. - Drug Profiles 11 Retinal Pigment Epithelium Program 11 Product Description 11 Mechanism of Action 11 R&D Progress 11 Hemangioblast Program 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 Mesenchymal Stem Cell Program 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Ocular Programs 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 Advanced Cell Technology, Inc. - Pipeline Analysis 16 Advanced Cell Technology, Inc. - Pipeline Products by Route of Administration 16 Advanced Cell Technology, Inc. - Pipeline Products by Molecule Type 17 Advanced Cell Technology, Inc. - Recent Pipeline Updates 18 Advanced Cell Technology, Inc. - Company Statement 27 Advanced Cell Technology, Inc. - Locations And Subsidiaries 29 Head Office 29 Other Locations & Subsidiaries 29 Appendix 30 Methodology 30 Coverage 30 Secondary Research 30 Primary Research 30 Expert Panel Validation 30 Contact Us 31 Disclaimer 31
List of Tables Advanced Cell Technology, Inc., Key Information 4 Advanced Cell Technology, Inc., Key Facts 4 Advanced Cell Technology, Inc. - Pipeline by Indication, 2014 6 Advanced Cell Technology, Inc. - Pipeline by Stage of Development, 2014 7 Advanced Cell Technology, Inc. - Monotherapy Products in Pipeline, 2014 8 Advanced Cell Technology, Inc. - Phase I, 2014 9 Advanced Cell Technology, Inc. - Preclinical, 2014 10 Advanced Cell Technology, Inc. - Pipeline by Route of Administration, 2014 16 Advanced Cell Technology, Inc. - Pipeline by Molecule Type, 2014 17 Advanced Cell Technology, Inc. - Recent Pipeline Updates, 2014 18 Advanced Cell Technology, Inc., Other Locations 29 Advanced Cell Technology, Inc., Subsidiaries 29
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.